65,437 trials
Schizophrenia
Primary: Scale for the Assessment of Negative Symptoms (SANS) Total Score — 33.23; 36.63; 36.63; 30.07 units on a scale
Contraception · Body Weight
Primary: Maximum Serum Concentration Between Normal and Obese BMI Women Ingesting 1.5mg Levonorgestrel — 10.3; 5.57 ng/mL
Hypertension, Pulmonary
Primary: Change in Right Ventricular Ejection Fraction — 7.45; 2.8 percent change — p=0.03
Schizophrenia
Primary: Change From Baseline on the Positive and Negative Syndrome Scale (PANSS) Positive Subscale — -2.4; -1.857; -5.889; -3.667 units on a scale
Low Back Pain
Primary: Participants With Adverse Events — 4; 2; 34; 25 Participants
Postoperative Pain
Primary: Postoperative Analgesia — 11.8; 15 milligrams of morphine — p=0.32
Knee Osteoarthritis
Primary: Change in Lower Quarter Y-Balance Test (YBT-LQ) (Dynamic Balance) From Baseline to 6 Weeks Following Total Knee Replacement — 69.98; 67.52; 73.25; 73.32 % of limb length…
Raynaud's Disease
Primary: Percentage of Patient Reported Pain-free Days — 12; 48 percentage of pain free days
Asthma
Primary: Absolute Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) at Week 12: High Eosinophils -Intent to Treat (HEos-ITT) Population — 1.86; 1.77; 1.8; 1.87…
Tachycardia
Primary: Complication Free Rate — 96.3 percentage of all subjects
Peripheral Nervous System Diseases · Pain Management · Self Management
Primary: Change in 0 - 10 Numerical Rating Scale of Worst Pain Intensity Scores at 8 Weeks — -0.94; 0 units on a scale — p=<0.05
Depression
Primary: Hamilton Rating Scale for Depression-17 Item — 19.0; 19.9; 19.4; 13.9 units on a scale — p=.95
Nasal Polyps
Primary: Change From Baseline in Bilateral Endoscopic Nasal Polyp Score (NPS) at Week 16 — 5.67; 5.87; 5.39; 3.97 score on a scale — p=0.0009
Type 2 Diabetes Mellitus
Primary: Reduction of HbA1c From Baseline — -0.85; -0.80; -0.46 Percent (%)
Hepatitis C, Chronic
Primary: Number of Participants Achieving eRVR — 23; 21; 9; 9 Participants